Zum Inhalt springen

COUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer

Dr. Peloso to lead COUR’s clinical development programs as the company advances towards late-stage development Dr. Peloso to lead COUR’s clinical development programs as the company advances towards late-stage development

COUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer
Autoren-Avatar
LabNews Media LLC
LabNews: Biotech. Digital Health. Life Sciences. Pugnalom: Environmental News. Nature Conservation. Climate Change. augenauf.blog: Wir beobachten Missstände

Entdecke mehr von LabNews

Jetzt abonnieren, um weiterzulesen und auf das gesamte Archiv zuzugreifen.

Weiterlesen